2 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
Follow Overweight or Obese: new trials by email Literature Review of Overweight or Obese trials Research Report on Overweight or Obese
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function BGM0504 - Type 2 Diabetes Mellitus (T2DM), Overweight or Obese | Phase 1 | Completed | BrightGene Bio-Medical Technology Co., Ltd. | 34 | 2025-05-06 | 2026-10-13 |
| A Study of BGM0504 in Overweight or Obese Participants Paracetamol, Metformin Hydrochloride, Warfarin - Overweight or Obese | Phase 1 | Completed | BrightGene Bio-Medical Technology Co., Ltd. | 28 | 2025-03-25 | 2026-10-13 |
| A Study to Evaluate MWN109 Injection in Healthy Subjects Placebo, Subcutaneous single and mutiple dose - Overweight or Obese | Phase 1 | Recruiting | Shanghai Minwei Biotechnology Co., Ltd | 72 | 2025-03-17 | 2025-04-15 |
Obesity (3) · Overweight (3) · Diabetes Mellitus, Type 2 (1)
Body Weight (3) · Nutrition Disorders (3) · Nutritional and Metabolic Diseases (3) · Overnutrition (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1)
Acetaminophen (1) · Metformin (1) · Warfarin (1)
BrightGene Bio-Medical Technology Co., Ltd. (2) · Shanghai Minwei Biotechnology Co., Ltd (1)
China (2) · Australia (1)
Guitao Zhang (1)